CRISPR-enhanced Engineering of Therapy-Sensitive Cancer Cells for Self-Targeting of Primary and Metastatic Tumors
Science Translational Medicine - United States
doi 10.1126/scitranslmed.aao3240
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 11, 2018
Authors
Publisher
American Association for the Advancement of Science (AAAS)